Quantitative comparison of glucagon-like peptide-1 receptor agonists on weight loss in adults: a systematic review and model-based meta-analysis
Zhang S, Yu B, Xu J, et al.
Diabetes Technol Ther. Pub. online 6 Feb 2025.
Leggi
Patient and physician factors driving the gaps in use of drugs with cardiovascular and kidney benefits by medicare beneficiaries with type 2 diabetes treated by endocrinologists, nephrologists, and cardiologists: population-based cohort study
McCoy RG, Vandergrift JL, Gray B
Diabetes Res Clin Pract. 2025:112039.
Leggi
Time in targeted blood glucose range as an independent predictor of 28-day mortality in ICU patients: a retrospective study
Zhao J, Huang D, Hua S, et al.
Diabetes Res Clin Pract. 2025:112033.
Leggi
Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients
Graf S, Hofer G, Hirschmann R, et al.
Diabetes Res Clin Pract. 2025:112035.
Leggi
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: a post hoc participant-level analysis of the ONWARDS 1-5 trials
Rossing P, Benamar M, Cheng AYY, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
Catarinella D, Melzi R, Mercalli A, et al.
Lancet Diabetes Endocrinol. Pub. online 6 Feb 2025.
Leggi
Lung function impairment and risks of incident cardiovascular diseases and mortality among people with type 2 diabetes: a prospective cohort study
Chen C, Huang Z, Liu L, et al.
Diabetes Care. 2025:dc242188.
Leggi
Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes: a longitudinal analysis
Desouter AK, Keymeulen B, Van de Velde U, et al.
Diabetes Care. 2025 Feb 4:dc242376.
Leggi